REDHILL BIOPHARMA LTD. Cash And Cash Equivalents
REDHILL BIOPHARMA LTD. (RDHL) had Cash And Cash Equivalents of $2.87 million as of 2025-06-30, per its 6-K filed 2025-09-05.
Financial Statements › Notes
ifrs-full:CashAndCashEquivalents · last filed 2025-09-05
- 2025-06-30: Cash And Cash Equivalents $2.87M.
- 2024-12-31: Cash And Cash Equivalents $4.62M.
- 2024-06-30: Cash And Cash Equivalents $7.28M.
- 2023-12-31: Cash And Cash Equivalents $5.57M.
| Period end | Cash And Cash Equivalents |
|---|---|
| 2025-06-30 | $2.87M 6-K · filed 2025-09-05 |
| 2024-12-31 | $4.62M 6-K · filed 2025-09-05 |
| 2024-06-30 | $7.28M 6-K · filed 2025-09-05 |
| 2023-12-31 | $5.57M 6-K · filed 2025-09-05 |
| 2023-06-30 | $7.00M 6-K · filed 2024-08-29 |
| 2022-12-31 | $19.97M 20-F · filed 2025-04-10 |
| 2022-06-30 | $26.99M 6-K · filed 2023-08-17 |
| 2022-03-31 | $28.85M 6-K · filed 2022-11-07 |
| 2021-12-31 | $29.47M 20-F · filed 2025-04-10 |
| 2021-06-30 | $51.82M 6-K · filed 2022-11-07 |
| 2021-03-31 | $75.97M 6-K · filed 2022-11-07 |
| 2020-12-31 | $29.30M 20-F · filed 2024-04-08 |
| 2020-06-30 | $22.27M 6-K · filed 2021-08-26 |
| 2020-03-31 | $81.61M 6-K · filed 2021-08-26 |
| 2019-12-31 | $29.02M 20-F · filed 2023-04-28 |
| 2019-06-30 | $8.99M 6-K · filed 2020-08-13 |
| 2019-03-31 | $23.01M 6-K · filed 2020-08-13 |
| 2018-12-31 | $29.00M 20-F · filed 2022-03-17 |
| 2018-06-30 | $5.56M 6-K · filed 2019-07-23 |
| 2018-03-31 | $7.56M 6-K · filed 2019-07-23 |
| 2017-12-31 | $16.45M 20-F · filed 2021-03-18 |
| 2017-06-30 | $15.32M 6-K · filed 2018-08-30 |
| 2017-03-31 | $29.62M 6-K · filed 2018-08-30 |
| 2016-12-31 | $53.79M 20-F · filed 2020-03-04 |
| 2015-12-31 | $21.52M 20-F · filed 2019-02-26 |
| 2014-12-31 | $5.89M 20-F · filed 2018-02-22 |